ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ADC Therapeutics SA changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 53 | 55 | +2 |
| Shares | 32.8M | 33.8M | +1.01M (+3.1%) |
| Value | $890.6M | $682.8M | −$207.9M (−23.3%) |
New holders (11)
Institutions that held ADC Therapeutics SA at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 45,478 | $919.0K | 0.03% |
| Millennium Management LLC | 40,367 | $815.0K | 0.00% |
| Susquehanna International Group, LLP | 25,866 | $522.0K | 0.00% |
| Caas Capital Management LP | 12,958 | $262.0K | 0.02% |
| UBS Group AG | 2,426 | $49.0K | 0.00% |
| Lazard Asset Management LLC | 1,863 | $37.0K | 0.00% |
| Sterling Investment Advisors, Ltd. | 1,100 | $22.0K | 0.01% |
| CWM, LLC | 950 | $19.0K | 0.00% |
| Group One Trading, L.P. | 100 | $2.00K | 0.00% |
| Citigroup Inc | 32 | $1.00K | 0.00% |
| Simplex Trading, LLC | 89 | $1.00K | 0.00% |
Sold out (9)
Institutions that held ADC Therapeutics SA at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Bailard, Inc. | 72,000 | $1.96M |
| Voloridge Investment Management, LLC | 30,847 | $838.0K |
| Man Group plc | 19,813 | $538.0K |
| Citadel Advisors LLC | 19,346 | $525.0K |
| Snowden Capital Advisors LLC | 14,323 | $389.0K |
| Cubist Systematic Strategies, LLC | 9,256 | $251.0K |
| Deutsche Bank AG | 300 | $8.00K |
| Brewin Dolphin Ltd | 115 | $3.12K |
| Point72 Hong Kong Ltd | 2 | $0 |